Recall: D-0741-2021
Class II - Potentially Harmful
Class IIClassification
2021-07-29Initiated
TerminatedStatus
Teva Pharmaceuticals USAFirm
Product
Metoclopramide Injection USP, 10 mg/2mL (5 mg/mL) 2 mL single-use vial, Rx only, Teva Parenteral Medicines, Inc. Irvine, CA 92618, NDC 0703-4502-01
Reason
Lack of Assurance of Sterility
Distribution
Product was distributed Nationwide, including Puerto Rico.
Source: FDA drug enforcement report via openFDA (Voluntary: Firm initiated). If you take this product, talk to your pharmacist or doctor before stopping it.